China Cord Blood Corp. (NYSE:CO) shares reached a new 52-week low on Monday . The stock traded as low as $5.32 and last traded at $5.36, with a volume of 21,501 shares changing hands. The stock had previously closed at $5.36.

Separately, Zacks Investment Research cut shares of China Cord Blood Corp. from a “hold” rating to a “sell” rating in a report on Tuesday, July 19th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $8.33.

The company’s 50 day moving average price is $5.63 and its 200 day moving average price is $5.94. The firm has a market capitalization of $392.03 million and a price-to-earnings ratio of 28.72.

China Cord Blood Corp. (NYSE:CO) last announced its earnings results on Tuesday, June 14th. The company reported $0.03 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.03. The business had revenue of $24.30 million for the quarter. Equities analysts predict that China Cord Blood Corp. will post $0.17 EPS for the current year.

China Cord Blood Corporation is principally engaged in the provision of umbilical cord blood storage and ancillary services in the People’s Republic of China. The Company provides cord blood testing, processing and storage services under the direction of subscribers. The Company also preserves cord blood units donated by the public, provides matching services on such donated units and delivers matching units to patients in need of transplants.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.